/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | NVNOenVVeno Medical Corp |
|---|---|
| Last close | $6.85close 2026-11-09 |
| Change % | +1.78%close 2026-11-09 |
| Market cap | $5Mclose 2026-11-09 |
| P/E | loss, no P/E |
| Revenue | $31243⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax As ofFY ending 2019-12-31 Filing10-K · 0001493152-21-007526 · filed 2021-03-31 Open the filing on EDGAR → |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -83.3%FY to 2019-12-31, older period |
| Net income | $-19472000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEF 14A · 0001140361-26-041182 · filed 2026-10-29 Open the filing on EDGAR →Open the XBRL payload →CiteenVVeno Medical Corp (NVNO), us-gaap:NetIncomeLoss: -19,472,000 USD, fiscal year ended 2025-12-31. Form DEF 14A, accession 0001140361-26-041182, filed 2026-10-29. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001661053/us-gaap/NetIncomeLoss.json |
| Net margin | periods differ |
| EPS (diluted) | $-33.06⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001493152-26-012928 · filed 2026-03-26 Open the filing on EDGAR →Open the XBRL payload →CiteenVVeno Medical Corp (NVNO), us-gaap:EarningsPerShareDiluted: -33.06 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001493152-26-012928, filed 2026-03-26. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001661053/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 3FY to 2019-12-31, older period |
| Altman Z-ScoreUNVALIDATED | -29.26FY to 2019-12-31, older period |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | rep. 04-29 |